Cointime

Akouos

company

About

Akouos is a biotechnology company focusing on restoring and preserving hearing.

  • 101 - 250

Highlights

Total Funding Amount
$105M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$105M
Industries
Biotechnology,Health Diagnostics,Pharmaceutical
Founded date
Jan 1, 2016
Number Of Employee
101 - 250
Operating Status
Active

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$105M
Akouos has raised a total of $105M in funding over 2 rounds. Their latest funding was raised on Mar 3, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 3, 2020 Series B $105M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Akouos is funded by 1 investors. Polaris Founders Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Polaris Founders Capital — Series B
Cointime
เนื้อหา
บริษัท